Avicanna Inc., a biopharmaceutical company specializing in cannabinoid-based products, has closed a non-brokered private placement raising approximately $2 million through the sale of 2,000 non-convertible debenture units. Each unit includes $1,000 principal debentures with 13% annual interest and 2,000 warrants exercisable at $0.20 per share for three years. The funds will support Avicanna's working capital, production, research, and clinical development as it continues expanding its product portfolio and commercial operations globally. This financing enhances the company's financial flexibility while focusing on operational efficiency and growth.
Avicanna's recent private placement is presented here with Pluang's health sector market data for context. For readers following health stocks, 106 of 150 traded US health-sector stocks rose while 44 fell. Notable movers include ALNY at USD 177.80 with a 23.49% drop, INO at USD 0.77 down 17.07%, and MESO at USD 15.63 up 16.73%. This data is as of Oct 30, 2026 03:11 WIB.
iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...
Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...
MetaMask has integrated Stellar as a default network in both its mobile app and browser extension, allowing users to manage XLM and other Stellar assets directly within the wallet. This integration uses existing recovery phrases to generate Stellar a...
NEO Battery Materials Ltd. reported Q2 2026 revenue of CAD 203,566 with a gross loss reflecting early-stage production scale-up. The company secured significant contracts including its first direct order from the Republic of Korea Army, a large found...
Polaris Inc. announced a quarterly cash dividend of $0.68 per share, payable on December 15, 2026, to shareholders recorded by December 1, 2026. This dividend reflects Polaris's ongoing commitment to returning value to its shareholders. As a global l...
